In addition to the commentary you’ll find in the Roundtable – from important issues in 2024 to representation in health care to AI (of course) to influencers, and much more – here are additional themes we heard from both agency folks as well as other industry subject matter experts about the year ahead.
Tag Archive for: patient privacy
The coming decades could see an astounding transformation in drug discovery due to AI. But experts say it’s critical to deal now with potential ethical and social justice landmines that may be encountered on the way to this new era.
Sheyda Karvar, SVP of Media Strategy at Fingerpaint, shares her observations from this year’s Digital Pharma East (DPE), where industry leaders came together for an immersive and informative series of panel discussions and presentations on healthcare’s top trends and opportunities.
A U.S. federal judge said Meta Platforms must face a lawsuit claiming that it violated the medical privacy of patients who were treated by hospitals and other healthcare providers that used its Meta Pixel tracking tool.
In the ever-changing world of digital marketing, staying ahead of the curve is critical for healthcare brands looking to effectively reach Patient X. With the impending demise of third-party cookies, marketers must adapt their strategies to continue connecting with prospective patients in a relevant and impactful manner.
Finding ways to deliver personalized ads leaving out personal identifying information is especially crucial in the pharmaceutical marketing landscape where data privacy is essential.
This article explores several emerging identity standards and what’s needed for the successful planning, activation, and measurement of advertising campaigns in the near future.
Med Ad News talked to Ittai Dayan, M.D., co-founder and CEO of Rhino Health, about federated learning in clinical trials.
Federal regulation of data privacy and security has been on the back burner for the past two years, but key members of Congress have been working behind the scenes to frame bipartisan legislation and the FTC is gearing up. The Supreme Court’s decision overturning Roe v. Wade may put this issue front and center in Congress after the midterms.
